ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adult Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,654Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 59

$714K Total Retail Price of All Prescriptions

Rank: 13 out of 59

527 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 527 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 10,545 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 1,422 1,165 1 1
LISINOPRIL 773 619 2 2
LEVOTHYROXINE SODIUM 542 486 3 3
METFORMIN HCL 462 387 4 6
OMEPRAZOLE 448 399 5 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 388 380 6 18
ACTOS 260 230 7 73
AMLODIPINE BESYLATE 238 220 8 4
HYDROCODONE-ACETAMINOPHEN 236 170 S3 9 5
HYDROCHLOROTHIAZIDE 233 184 10 11
FUROSEMIDE 231 195 11 8
NAPROXEN 203 152 12 69
ALENDRONATE SODIUM 180 162 13 20
LOSARTAN POTASSIUM 177 145 14 19
PRAVASTATIN SODIUM 176 150 15 21
DOXAZOSIN MESYLATE 171 163 16 97
ATENOLOL 164 126 17 28
POTASSIUM CHLORIDE 152 128 18 16
EVISTA 151 145 19 91
METOPROLOL SUCCINATE 145 125 20 12
TRIAMTERENE-HCTZ 134 104 21 82
LOVASTATIN 115 104 22 43
METOPROLOL TARTRATE 115 92 22 9
LOSARTAN-HYDROCHLOROTHIAZIDE 112 90 24 39
GLYBURIDE 111 95 R 25 48
PIOGLITAZONE HCL 111 97 R 25 177
ATORVASTATIN CALCIUM 105 101 27 15
NEXIUM 103 56 28 14
CLONIDINE HCL 97 81 29 55
ALLOPURINOL 96 80 30 42
CLOPIDOGREL 92 84 31 35
AMITRIPTYLINE HCL 87 57 R 32 99
MECLIZINE HCL 87 63 32 72
PANTOPRAZOLE SODIUM 86 53 34 33
AMOXICILLIN 86 58 34 114
GABAPENTIN 84 36 36 13
SERTRALINE HCL 83 75 37 22
CRESTOR 80 58 38 23
CITALOPRAM HBR 79 76 39 25
WARFARIN SODIUM 77 47 40 30
ATENOLOL-CHLORTHALIDONE 73 65 41 165
PLAVIX 73 62 41 54
ADVAIR DISKUS 69 60 43 58
TAMSULOSIN HCL 68 64 44 27
FLUOXETINE HCL 62 49 45 105
NIASPAN 61 48 46 118
GEMFIBROZIL 59 48 47 110
INSULIN SYRINGE 58 31 48 67
SPIRIVA 57 52 49 78
SPIRONOLACTONE 56 29 50 81
LEVEMIR 55 35 51 106
ZOLPIDEM TARTRATE 54 42 52 17
CLARITHROMYCIN 52 37 53 233
LYRICA 52 31 53 71
CARVEDILOL 52 42 53 31
PAROXETINE HCL 51 51 56 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 10, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.